Aleth (from the Greek for pure truth) is an open-access research platform focused on scientific innovation across life sciences, AI, and deep tech. Built AI-native with rigorous human oversight of the research process.
This site hosts our permanent research archive, while the live insights drop directly into your inbox. Subscribe for free via Substack to get our latest life sciences, AI and deep tech analysis the moment it’s published. Subscribe free at sub.aleth.co (opens in new tab)
-
ALETH / LIFESCI-BRIEF / 2025-11-14 / BIG PROGRESS IN CARDIOLOGY AT AHA
Big progress in cardiology at AHA
-
ALETH / LIFESCI-BRIEF / 2025-11-07 / PFIZER AND NOVO GO TO WAR OVER METSERA
Pfizer and Novo go to war over Metsera
-
ALETH / LIFESCI-BRIEF / 2025-10-31 / NOVO GOES HOSTILE ON METSERA TO OUTBID PFIZER
Novo goes hostile on Metsera to outbid Pfizer
-
ALETH / LIFESCI-BRIEF / 2025-10-24 / HOLOGIC: BIGGEST DEVICE BUYOUT IN 20 YEARS
Hologic: biggest device buyout in 20 years
-
ALETH / LIFESCI-BRIEF / 2025-10-17 / ELLISON’S EIT TO INVEST AN EXTRA $1.2BN IN OXFORD
Ellison's EIT to invest an extra $1.2bn in Oxford
-
ALETH / LIFESCI-BRIEF / 2025-10-10 / PHARMA STOCKS ADD $440BN AFTER PRICING DEAL
Pharma stocks add $440bn after pricing deal
-
ALETH / LIFESCI-BRIEF / 2025-10-03 / GENMAB TO BUY DUTCH BIOTECH MERUS FOR $8BN
Genmab to buy Dutch biotech Merus for $8bn
-
ALETH / LIFESCI-BRIEF / 2025-09-26 / UNIQURE GENE THERAPY SLOWS HUNTINGTON’S
UniQure gene therapy slows Huntington's
-
ALETH / LIFESCI-BRIEF / 2025-09-19 / GSK TO INVEST $30BN IN THE US
GSK to invest $30bn in the US
-
ALETH / LIFESCI-BRIEF / 2025-09-12 / MERCK SCRAPS ITS $1BN+ LONDON LAB
Merck scraps its $1bn+ London lab
-
ALETH / LIFESCI-BRIEF / 2025-09-05 / ASTRAZENECA CRACKS RESISTANT HYPERTENSION
AstraZeneca cracks resistant hypertension
-
ALETH / LIFESCI-BRIEF / 2025-08-29 / BRITAIN'S DRUG PRICING TALKS COLLAPSE
Britain's drug pricing talks collapse
-
ALETH / LIFESCI-BRIEF / 2025-08-22 / US AND EU CAP PHARMA TARIFFS AT 15%
US and EU cap pharma tariffs at 15%
-
ALETH / LIFESCI-BRIEF / 2025-08-15 / US BIOTECH GOES SIX MONTHS WITHOUT AN IPO
US biotech goes six months without an IPO
-
ALETH / LIFESCI-BRIEF / 2025-08-08 / LILLY'S OBESITY PILL MISSES, NOVO REBOUNDS
Lilly's obesity pill misses, Novo rebounds
-
ALETH / LIFESCI-BRIEF / 2025-08-01 / NOVO NORDISK LOSES ITS OBESITY LEAD
Novo Nordisk loses its obesity lead
-
ALETH / LIFESCI-BRIEF / 2025-07-25 / ASTRAZENECA PLEDGES 50BN TO THE US
AstraZeneca pledges $50bn to the US
-
ALETH / LIFESCI-BRIEF / 2025-07-18 / EIGHT UK BABIES BORN FROM THREE-PERSON IVF
Eight UK babies born from three-person IVF
-
ALETH / LIFESCI-BRIEF / 2025-07-11 / MERCK BUYS UK'S VERONA PHARMA FOR $10BN
Merck buys UK'S Verona Pharma for $10bn
-
ALETH / LIFESCI-BRIEF / 2025-07-04 / ASTRAZENECA EYES QUITTING LONDON LISTING FOR US
AstraZeneca eyes quitting London listing for US